Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-09-25

Clinical Trial Update: Management of Metastatic Breast Cancer in Frail Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating management of metastatic breast cancer in frail patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Breast Cancer | Phase 2 | Status: WITHDRAWN